| Tag |
Content |
LipidDB ID |
LipidDB-10377-00302 |
Entry Name |
|
UniProt Accession |
|
Theoretical PI |
4.85 |
Molecular Weight |
53011.46 |
Genbank Protein ID |
|
Genbank Nucleotide ID |
|
Protein Name |
Latent membrane protein 2 |
Protein Synonyms/Alias |
Terminal protein; |
Gene Name |
LMP2 |
Gene Synonyms/Alias |
|
Created Date |
01-JAN-1990 |
| Lipid Modification Sites |
| Position |
Sequence Form |
Peptide |
References |
Modification Type |
124 | Canonical | RGSMNPVCLPVIVAP | [1] | S-Palmitoylation | 245 | Canonical | RWRRLTVCGGIMFLA | [1] | S-Palmitoylation | 339 | Canonical | TLVVLLICSSCSSCP | [1] | S-Palmitoylation | 342 | Canonical | VLLICSSCSSCPLSK | [1] | S-Palmitoylation | 345 | Canonical | ICSSCSSCPLSKILL | [1] | S-Palmitoylation | 426 | Canonical | TYGPVFMCLGGLLTM | [1] | S-Palmitoylation | 472 | Canonical | ALFGVIRCCRYCCYY | [1] | S-Palmitoylation | 473 | Canonical | LFGVIRCCRYCCYYC | [1] | S-Palmitoylation | 476 | Canonical | VIRCCRYCCYYCLTL | [1] | S-Palmitoylation | 477 | Canonical | IRCCRYCCYYCLTLE | [1] | S-Palmitoylation | 480 | Canonical | CRYCCYYCLTLESEE | [1] | S-Palmitoylation |
|
Organism |
Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4) |
NCBI Taxa ID |
10377 |
Reference |
[1] Katzman RB, Longnecker R. LMP2A does not require palmitoylation to localize tobuoyant complexes or for function. J Virol. 2004 Oct;78(20):10878-87. PubMedPMID: 15452208; PubMed Central PMCID: PMC521828.[ PMID:15452208]
|
Functional Description |
Isoform LMP2A maintains EBV latent infection of B- lymphocyte, by preventing lytic reactivation of the virus in response to surface immunoglobulin (sIg) cross-linking. Acts like a dominant negative inhibitor of the sIg-associated protein tyrosine kinases, LYN and SYK. Also blocks translocation of the B- cell antigen receptor (BCR) into lipid rafts, preventing the subsequent signaling and accelerated internalization of the BCR upon BCR cross-linking. Serves as a molecular scaffold to recruit SYK, LYN and E3 protein-ubiquitin ligases, such as ITCH and NEDD4L, leading to ubiquitination and potential degradation of both tyrosines kinases. Possesses a constitutive signaling activity in non-transformed cells, inducing bypass of normal B lymphocyte developmental checkpoints allowing immunoglobulin- negative cells to colonize peripheral lymphoid organs. |
Sequence Annotation |
Topological domain: 1 123 Cytoplasmic. Transmembrane: 124 144 Helical. Topological domain: 145 147 Extracellular. Transmembrane: 148 168 Helical. Topological domain: 169 177 Cytoplasmic. Transmembrane: 178 198 Helical. Topological domain: 199 211 Extracellular. Transmembrane: 212 232 Helical. Topological domain: 233 241 Cytoplasmic. Transmembrane: 242 262 Helical. Topological domain: 263 267 Extracellular. Transmembrane: 268 288 Helical. Topological domain: 289 296 Cytoplasmic. Transmembrane: 297 317 Helical. Topological domain: 318 318 Extracellular. Transmembrane: 319 339 Helical. Topological domain: 340 354 Cytoplasmic. Transmembrane: 355 375 Helical. Topological domain: 376 388 Extracellular. Transmembrane: 389 409 Helical. Topological domain: 410 422 Cytoplasmic. Transmembrane: 423 443 Helical. Topological domain: 444 449 Extracellular. Transmembrane: 450 470 Helical. Topological domain: 471 497 Cytoplasmic. Motif: 97 101 PPPPY WW-binding. Modified residue: 112 112 Phosphotyrosine; by host.
|
Protein Length |
497 AA. |
Protein Sequence (Canonical) |
MGSLEMVPMG AGPPSPGGDP DGYDGGNNSQ YPSASGSSGN TPTPPNDEER ESNEEPPPPY 60
EDPYWGNGDR HSDYQPLGTQ DQSLYLGLQH DGNDGLPPPP YSPRDDSSQH IYEEAGRGSM 120
NPVCLPVIVA PYLFWLAAIA ASCFTASVST VVTATGLALS LLLLAAVASS YAAAQRKLLT 180
PVTVLTAVVT FFAICLTWRI EDPPFNSLLF ALLAAAGGLQ GIYVLVMLVL LILAYRRRWR 240
RLTVCGGIMF LACVLVLIVD AVLQLSPLLG AVTVVSMTLL LLAFVLWLSS PGGLGTLGAA 300
LLTLAAALAL LASLILGTLN LTTMFLLMLL WTLVVLLICS SCSSCPLSKI LLARLFLYAL 360
ALLLLASALI AGGSILQTNF KSLSSTEFIP NLFCMLLLIV AGILFILAIL TEWGSGNRTY 420
GPVFMCLGGL LTMVAGAVWL TVMSNTLLSA WILTAGFLIF LIGFALFGVI RCCRYCCYYC 480
LTLESEERPP TPYRNTV 497
|
FASTA (Canonical) |
>LipidDB-10377-00302|P13285
MGSLEMVPMGAGPPSPGGDPDGYDGGNNSQYPSASGSSGNTPTPPNDEERESNEEPPPPY
EDPYWGNGDRHSDYQPLGTQDQSLYLGLQHDGNDGLPPPPYSPRDDSSQHIYEEAGRGSM
NPVCLPVIVAPYLFWLAAIAASCFTASVSTVVTATGLALSLLLLAAVASSYAAAQRKLLT
PVTVLTAVVTFFAICLTWRIEDPPFNSLLFALLAAAGGLQGIYVLVMLVLLILAYRRRWR
RLTVCGGIMFLACVLVLIVDAVLQLSPLLGAVTVVSMTLLLLAFVLWLSSPGGLGTLGAA
LLTLAAALALLASLILGTLNLTTMFLLMLLWTLVVLLICSSCSSCPLSKILLARLFLYAL
ALLLLASALIAGGSILQTNFKSLSSTEFIPNLFCMLLLIVAGILFILAILTEWGSGNRTY
GPVFMCLGGLLTMVAGAVWLTVMSNTLLSAWILTAGFLIFLIGFALFGVIRCCRYCCYYC
LTLESEERPPTPYRNTV
|
Gene Ontology |
GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-KW GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-KW GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW GO:0039649; P:modulation by virus of host ubiquitin-protein ligase activity; IEA:UniProtKB-KW GO:0019042; P:viral latency; IEA:InterPro |
Interpro |
|
Pfam |
|
SMART |
|
PROSITE |
|
PRINTS |
|